Literature DB >> 9852946

A new membrane-bound OprI lipoprotein expression vector. High production of heterologous fusion proteins in gram (-) bacteria and the implications for oral vaccination.

J Cote-Sierra1, E Jongert, A Bredan, D C Gautam, M Parkhouse, P Cornelis, P De Baetselier, H Revets.   

Abstract

We have previously described the development of cloning vectors for the production of OprI-based outer membrane fusion proteins in E. coli (Cornelis et al., 1996) and now describe the construction of a new vector, containing a lacI(q) gene, resulting in tight repression of the promotor and allowing its use in other Gram (-) bacteria. The new pVUB3 expression vector encodes a truncated but active LacI(q)(341) repressor which binds to the single operator in the vector. A high repression of the trc promotor was observed, resulting in a very low basal leakage of expression and very high production levels of OprI or derivatives after IPTG induction in E. coli. Bacterial viability was not affected under uninduced conditions, but the number of viable cell counts decreased after production of large amounts of the outer membrane-bound OprI lipoprotein and its derivatives, both in E. coli and Salmonella typhimurium. This highly repressible system allows us to extend the use of OprI vectors in other Gram (-) bacteria, resulting in the production of outer membrane-bound lipid-modified molecules, opening the possibility for its application in the design of potential live Salmonella-based subunit vaccines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852946     DOI: 10.1016/s0378-1119(98)00437-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

Review 1.  Challenges in the production of itaconic acid by metabolically engineered Escherichia coli.

Authors:  Kouhei Yamamoto; Keisuke Nagata; Hitomi Ohara; Yuji Aso
Journal:  Bioengineered       Date:  2015-07-15       Impact factor: 3.269

2.  Novel bacterial membrane surface display system using cell wall-less L-forms of Proteus mirabilis and Escherichia coli.

Authors:  Christian Hoischen; Christine Fritsche; Johannes Gumpert; Martin Westermann; Katleen Gura; Beatrix Fahnert
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

3.  Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.

Authors:  Javier Cote-Sierra; Amin Bredan; Carmen M Toldos; Benoit Stijlemans; Lea Brys; Pierre Cornelis; Manuel Segovia; Patrick de Baetselier; Hilde Revets
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate.

Authors:  J Keenan; J Oliaro; N Domigan; H Potter; G Aitken; R Allardyce; J Roake
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Outer membrane protein I of Pseudomonas aeruginosa is a target of cationic antimicrobial peptide/protein.

Authors:  Yu-Min Lin; Shih-Jung Wu; Ting-Wei Chang; Chiu-Feng Wang; Ching-Shu Suen; Ming-Jing Hwang; Margaret Dah-Tsyr Chang; Yuan-Tsong Chen; You-Di Liao
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

6.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.